The RBC Life Science and Technology Fund is an actively managed ETF that seeks capital appreciation by investing in a portfolio comprised primarily of U.S. tech companies.
The RBC Life Science and Technology Fund (CAD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Technologies sector located in USA. The Royal Bank of Canada GAM fund’s base currency is CAD and the share class was registered 30.08.2024 with unique ISIN - CA7492921084. Main exchange is Cboe Canada and ticker symbol is RLST. The total expense ratio is 0.75%. The RBC Life Science and Technology Fund (CAD) pays dividends 1 time(s) per year.